These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 39114808)

  • 1. Chitosan non-particulate vaccine delivery systems.
    Masimov R; Wasan EK
    J Pharm Pharm Sci; 2024; 27():12921. PubMed ID: 39114808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
    Gordon S; Saupe A; McBurney W; Rades T; Hook S
    J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Modification of Chitosan for Efficient Vaccine Delivery.
    Xing L; Fan YT; Zhou TJ; Gong JH; Cui LH; Cho KH; Choi YJ; Jiang HL; Cho CS
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29370100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems.
    Gordon S; Young K; Wilson R; Rizwan S; Kemp R; Rades T; Hook S
    J Liposome Res; 2012 Sep; 22(3):193-204. PubMed ID: 22188610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
    Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
    Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases.
    Singh B; Maharjan S; Cho KH; Cui L; Park IK; Choi YJ; Cho CS
    Int J Biol Macromol; 2018 Apr; 110():54-64. PubMed ID: 29054527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel application of trimethyl chitosan as an adjuvant in vaccine delivery.
    Malik A; Gupta M; Gupta V; Gogoi H; Bhatnagar R
    Int J Nanomedicine; 2018; 13():7959-7970. PubMed ID: 30538470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-based hydrogels for controlled, localized drug delivery.
    Bhattarai N; Gunn J; Zhang M
    Adv Drug Deliv Rev; 2010 Jan; 62(1):83-99. PubMed ID: 19799949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled Liposome Delivery from Chitosan-Based Thermosensitive Hydrogel for Regenerative Medicine.
    Furlani F; Rossi A; Grimaudo MA; Bassi G; Giusto E; Molinari F; Lista F; Montesi M; Panseri S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery.
    Gordon S; Teichmann E; Young K; Finnie K; Rades T; Hook S
    Eur J Pharm Sci; 2010 Oct; 41(2):360-8. PubMed ID: 20633644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances on chitosan as an adjuvant for vaccine delivery.
    Dmour I; Islam N
    Int J Biol Macromol; 2022 Mar; 200():498-519. PubMed ID: 34973993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of chitosan and poloxamer based thermosensitive hydrogel for the delivery of PEGylated melphalan conjugates.
    Alexander A; Saraf S; Saraf S
    Drug Dev Ind Pharm; 2015; 41(12):1954-61. PubMed ID: 25678314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin-Chitosan Composite Hydrogels Induced by Microbial Transglutaminase: Potential Delivery Systems for Thermosensitive Bioactive Substances.
    Wang K; Sun H; Cui Z; Wang J; Hou J; Lu F; Liu Y
    J Agric Food Chem; 2024 Jun; 72(25):14302-14314. PubMed ID: 38865607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan and its derivatives in mucosal drug and vaccine delivery.
    van der Lubben IM; Verhoef JC; Borchard G; Junginger HE
    Eur J Pharm Sci; 2001 Oct; 14(3):201-7. PubMed ID: 11576824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable thermosensitive chitosan/glycerophosphate-based hydrogels for tissue engineering and drug delivery applications: a review.
    Tahrir FG; Ganji F; Ahooyi TM
    Recent Pat Drug Deliv Formul; 2015; 9(2):107-20. PubMed ID: 25354269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan.
    Popescu R; Ghica MV; Dinu-Pîrvu CE; Anuța V; Lupuliasa D; Popa L
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and physical chitosan hydrogels as prospective carriers for drug delivery: a review.
    Tian B; Hua S; Tian Y; Liu J
    J Mater Chem B; 2020 Nov; 8(44):10050-10064. PubMed ID: 33073280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in chitosan hydrogels carrying natural bioactive compounds.
    Do NHN; Truong QT; Le PK; Ha AC
    Carbohydr Polym; 2022 Oct; 294():119726. PubMed ID: 35868739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pH-responsive compounds synthesized from chitosan and hyaluronic acid on dual-responsive (pH/temperature) hydrogel drug delivery systems of Cortex Moutan.
    Chatterjee S; Hui PC; Siu WS; Kan CW; Leung PC; Wanxue C; Chiou JC
    Int J Biol Macromol; 2021 Jan; 168():163-174. PubMed ID: 33309656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.